NEWS

Orbit Discovery Announces $7.6M Funding to Accelerate Growth in Peptide Discovery Business	07.20.21
T-Cypher Bio Announces the Appointment of Thomas Lars Andresen as CEO	07.15.21
Compass Therapeutics to Acquire TRIGR Therapeutics	05.13.21
Compass Therapeutics Reports 2020 Results and Partial Response	03.05.21
T-Cypher Bio Separates from Orbit Discovery to Pursue TCR Therapeutics	02.25.21
Evox Therapeutics Completes $95.4 Million Series C Financing	02.18.21

Page 1 of 8